Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.
<h4>Objective</h4>To identify comorbidity indices that have been validated in cancer populations, with a focus on breast cancer and human epidermal growth factor receptor-2-positive (HER2+) breast cancer.<h4>Study design and setting</h4>A systematic review of the literature o...
Guardado en:
Autores principales: | Maribel Salas, Mackenzie Henderson, Meera Sundararajan, Nora Tu, Zahidul Islam, Mina Ebeid, Laura Horne |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07cd539080644ac4bd6e1fa68efb2d31 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer
por: Peng Yuan, et al.
Publicado: (2017) -
The prognostic effects of somatic mutations in ER-positive breast cancer
por: Obi L. Griffith, et al.
Publicado: (2018) - Breast cancer
-
Breast cancer
por: Liudmila G. Zhukova, et al.
Publicado: (2021) -
Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)